Int J Biol Sci
2022; 18(14):5309-5311.
doi:10.7150/ijbs.75891 This issueCite
Erratum
Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum
Deng-Pan Wu1,2*, Yan Zhou4*, Li-Xiang Hou1*, Xiao-Xiao Zhu1, Wen Yi1, Si-Man Yang3, Tian-Yu Lin1, Jin-Lan Huang1,2, Bei Zhang5, Xiao-Xing Yin1✉
1. Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Pharmacy School of Xuzhou Medical University, Xuzhou City, Jiangsu Province, 221004, P.R. China. 2. Department of Pharmacology, Pharmacy School of Xuzhou Medical University, 221004, Xuzhou City, Jiangsu Province, P.R. China. 3. Scientific research center of traditional Chinese medicine, Guangxi University of Chinese Medicine, Nanning City, Guangxi Zhuang Autonomous Region, P.R. China. 4. Clinical Pharmacy, Jingjiang People's Hospital, 214500, Jingjiang City, Jiangsu Province, P.R. China. 5. Department of gynaecology and obstetrics, Xuzhou Central Hospital, 221009, Xuzhou City, Jiangsu Province, P.R. China. *These authors contributed equally to this work.
✉ Corresponding author: Xiao-Xing Yin, PhD. Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Pharmacy School of Xuzhou Medical University; No.209 Tongshan Road, Xuzhou City, Jiangsu Province, 221004, P.R. China. E-mail: yinxxedu.cn; Tel: +86 516 83262134.More
Citation:
Wu DP, Zhou Y, Hou LX, Zhu XX, Yi W, Yang SM, Lin TY, Huang JL, Zhang B, Yin XX. Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum. Int J Biol Sci 2022; 18(14):5309-5311. doi:10.7150/ijbs.75891. https://www.ijbs.com/v18p5309.htm
Wu, D.P., Zhou, Y., Hou, L.X., Zhu, X.X., Yi, W., Yang, S.M., Lin, T.Y., Huang, J.L., Zhang, B., Yin, X.X. (2022). Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum. International Journal of Biological Sciences, 18(14), 5309-5311. https://doi.org/10.7150/ijbs.75891.
ACS
Wu, D.P.; Zhou, Y.; Hou, L.X.; Zhu, X.X.; Yi, W.; Yang, S.M.; Lin, T.Y.; Huang, J.L.; Zhang, B.; Yin, X.X. Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum. Int. J. Biol. Sci. 2022, 18 (14), 5309-5311. DOI: 10.7150/ijbs.75891.
NLM
Wu DP, Zhou Y, Hou LX, Zhu XX, Yi W, Yang SM, Lin TY, Huang JL, Zhang B, Yin XX. Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum. Int J Biol Sci 2022; 18(14):5309-5311. doi:10.7150/ijbs.75891. https://www.ijbs.com/v18p5309.htm
CSE
Wu DP, Zhou Y, Hou LX, Zhu XX, Yi W, Yang SM, Lin TY, Huang JL, Zhang B, Yin XX. 2022. Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum. Int J Biol Sci. 18(14):5309-5311.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.